Dabrafenib Mesylate and Rabeprazole Delayed Release Capsules
Determining the interaction of Dabrafenib Mesylate and Rabeprazole Delayed Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: rabeprazole
Brand name: Aciphex, AcipHex Sprinkle
Synonyms: Rabeprazole, RABEprazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Rabeprazole Delayed-Release Tablets
- Dabrafenib Mesylate-Rabeprazole Sodium
- Dabrafenib Mesylate-Rabeprazole Sprinkle Capsules
- Dabrafenib Mesylate-Rabies Immune Globulin
- Dabrafenib Mesylate-Rabies immune globulin human
- Dabrafenib Mesylate-Rabies immune globulin Intramuscular
- Rabeprazole Delayed Release Capsules-Dacarbazine
- Rabeprazole Delayed Release Capsules-Dacarbazine Intravenous, Injection
- Rabeprazole Delayed Release Capsules-Daclatasvir
- Rabeprazole Delayed Release Capsules-Daclatasvir Dihydrochloride
- Rabeprazole Delayed Release Capsules-Daclizumab
- Rabeprazole Delayed Release Capsules-Daclizumab Subcutaneous